Los Angeles Capital Management
MXCT icon

Los Angeles Capital Management’s MaxCyte MXCT Stock Holding History

Los Angeles Capital Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-63,330
Closed -$44.5K – 2440
2026
Q1 		$44.5K Hold
63,330
– – ﹤0.01% 1519
2025
Q4 		$95.6K Hold
63,330
– – ﹤0.01% 1427
2025
Q3 		$100K Hold
63,330
– – ﹤0.01% 1319
2025
Q2 		$138K Buy
+63,330
New +$153K ﹤0.01% 1233
2022
Q1 		– Sell
-34,220
Closed -$349K – 1462
2021
Q4 		$349K Buy
+34,220
New +$367K ﹤0.01% 1184

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Los Angeles Capital Management's MXCT Position: Q2 2026 in Review

Los Angeles Capital Management sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 63,330 shares — an estimated $44.5K sold.

Los Angeles Capital Management first reported a position in MXCT in Q4 2021 and held it in 5 quarters. The position peaked at $349K in Q4 2021. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Los Angeles Capital Management reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
  • Los Angeles Capital Management sold 63,330 MaxCyte shares in Q2 2026, an estimated $44.5K.
  • Los Angeles Capital Management first reported a position in MaxCyte in Q4 2021 and held it in 5 quarters.
  • Los Angeles Capital Management's MaxCyte position peaked at $349K in Q4 2021.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.